These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8632060)

  • 1. Modulation of acetylcholine receptor function in TE671 (rhabdomyosarcoma) cells by non-AChR ligands: possible relevance to seronegative myasthenia gravis.
    Li Z; Forester N; Vincent A
    J Neuroimmunol; 1996 Feb; 64(2):179-83. PubMed ID: 8632060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-acetylcholine receptor (AChR) antibodies measurement in myasthenia gravis: the use of cell line TE671 as a source of AChR antigen.
    Somnier FE
    J Neuroimmunol; 1994 Apr; 51(1):63-8. PubMed ID: 8157737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
    Blaes F; Beeson D; Plested P; Lang B; Vincent A
    Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures.
    Farrugia ME; Bonifati DM; Clover L; Cossins J; Beeson D; Vincent A
    J Neuroimmunol; 2007 Apr; 185(1-2):136-44. PubMed ID: 17335909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation.
    Spreadbury I; Kishore U; Beeson D; Vincent A
    J Neuroimmunol; 2005 May; 162(1-2):149-56. PubMed ID: 15833370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AChR phosphorylation and indirect inhibition of AChR function in seronegative MG.
    Plested CP; Tang T; Spreadbury I; Littleton ET; Kishore U; Vincent A
    Neurology; 2002 Dec; 59(11):1682-8. PubMed ID: 12473752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and pharmacological heterogeneity of alpha-bungarotoxin binding sites extracted from TE671 cells.
    Walker R; Vincent A; Newsom-Davis J
    J Neuroimmunol; 1988 Aug; 19(1-2):149-57. PubMed ID: 3397405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seronegative myasthenia gravis: a plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM.
    Yamamoto T; Vincent A; Ciulla TA; Lang B; Johnston I; Newsom-Davis J
    Ann Neurol; 1991 Oct; 30(4):550-7. PubMed ID: 1665051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyosarcoma cell line can be used for the isolation of soluble acetylcholine receptor and for assaying blocking and modulating autoantibodies.
    Wu JT; Astill M; Lloyd C; Salmon VC
    J Clin Lab Anal; 1993; 7(1):11-8. PubMed ID: 8426270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
    Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
    Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of anti-acetylcholine receptor auto-antibodies in myasthenia gravis.
    Steenkamp KJ; Duim W; Myer MS; Malfeld SC; Anderson R
    S Afr Med J; 1995 Dec; 85(12):1293-4. PubMed ID: 8600588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple antibody detection in 'seronegative' myasthenia gravis patients.
    Hong Y; Zisimopoulou P; Trakas N; Karagiorgou K; Stergiou C; Skeie GO; Hao HJ; Gao X; Owe JF; Zhang X; Yue YX; Romi F; Wang Q; Li HF; Gilhus NE; Tzartos SJ
    Eur J Neurol; 2017 Jun; 24(6):844-850. PubMed ID: 28470860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-p110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement.
    Scuderi F; Marino M; Colonna L; Mannella F; Evoli A; Provenzano C; Bartoccioni E
    Lab Invest; 2002 Sep; 82(9):1139-46. PubMed ID: 12218074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-acetylcholine receptor antibodies block bungarotoxin binding to native human acetylcholine receptor on the surface of TE671 cells.
    Pachner AR
    Neurology; 1989 Aug; 39(8):1057-61. PubMed ID: 2761699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of acetylcholine receptor expression in seronegative myasthenia gravis.
    Poea S; Guyon T; Bidault J; Bruand C; Mouly V; Berrih-Aknin S
    Ann Neurol; 2000 Nov; 48(5):696-705. PubMed ID: 11079532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: measurement of anti-AChR autoantibodies using cell line TE671.
    Voltz R; Hohlfeld R; Fateh-Moghadam A; Witt TN; Wick M; Reimers C; Siegele B; Wekerle H
    Neurology; 1991 Nov; 41(11):1836-8. PubMed ID: 1944918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis.
    Cardona A; Garchon HJ; Vernet-der-Garabedian B; Morel E; Gajdos P; Bach JF
    J Neuroimmunol; 1994 Aug; 53(1):9-16. PubMed ID: 8051300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future therapeutic strategies in autoimmune myasthenia gravis.
    Psaridi-Linardaki L; Mamalaki A; Tzartos SJ
    Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies affecting ion channel function in acquired neuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryposis multiplex congenita.
    Vincent A; Jacobson L; Plested P; Polizzi A; Tang T; Riemersma S; Newland C; Ghorazian S; Farrar J; MacLennan C; Willcox N; Beeson D; Newsom-Davis J
    Ann N Y Acad Sci; 1998 May; 841():482-96. PubMed ID: 9668280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an assay for modulating anti-acetylcholine receptor autoantibodies using human rhabdomyosarcoma cell line.
    Lyons BW; Wu LL; Astill ME; Wu JT
    J Clin Lab Anal; 1998; 12(5):315-9. PubMed ID: 9773965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.